2024 / 04

Next Paper
DOI: 10.24075/medet.2024.028
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

REVIEW

Evidence obtained during real world data analysis: what it is and how we form it

Verbitskaya EV, Kolbin AS
About authors

IP Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia

Correspondence shall be addressed: Elena Vladimirovna Verbitskaya
L’va Tolstogo Str., 6–8/1, Saint Petersburg, 197022, Russia; ur.tenretni@ayakstibreve

About paper

Author contribution: Verbitskaya EV and Kolbin AS made an equal contribution to the preparation of the article.

Received: 2024-11-02 Accepted: 2024-12-16 Published online: 2024-12-31
|
  1. Kolbin AS, et al. Issledovaniya, predstavlyayushchiye klinicheskuyu praktiku. M.: Izdatel’stvo OKI: Buki Ved, 2020. Available from URL: https://izdat-oki.ru/issledovaniya-realnoj-klinicheskoj-praktiki (accessed 10.05.2022). Russian.
  2. Eskola SM, Leufkens HG M, Bate A, De Bruin ML, and Gardarsdottir H, Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018–2019. Clin. Pharmacol. Ther. Jan. 2022; 111(1): 310–320. DOI: 10.1002/CPT.2462.
  3. Rudnicki M. Use of Real World Data (RWD) to generate Real World Evidence (RWE) in gynecologic surgery. Acta Obstetricia et Gynecologica Scandinavica. 2021; 100(12): 2133–2134. DOI: 10.1111/aogs.14292.
  4. Yevraziyskiy ekonomicheskiy soyuz. Ob obshchikh podkhodakh k razvitiyu regulirovaniya obrashcheniya lekarstvennykh sredstv v ramkakh Yevraziyskogo ekonomicheskogo soyuza v chasti sbora, analiza i ispol’zovaniya dannykh real’noy klinicheskoy praktiki. Rekomendatsiya Soveta Yevraziyskoy ekonomicheskoy komissii ot 18.10.2024. 2024; 1(1) Available from URL: https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=488573&dst=100001#lv8sBTUQZwxAADEo (accessed 04.11.2024). Russian.
  5. US Food & Drug Administration. Advancing Real-World Evidence Program. Available from URL: https://www.fda.gov/drugs/ development-resources/advancing-real-world-evidence-program. (accessed 04.11. 2024).
  6. Prilla S, et al. Real-World Evidence to Support EU Regulatory Decision Making-Results from a Pilot of Regulatory Use Cases. Clin Pharmacol Ther. Nov. 2024; 116(5). DOI: 10.1002/CPT.3355
  7. Jaksa A, Wu J, Jónsson P, Eichler HG, Vititoe S, and Gatto NM. Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance. J Comp Eff Res. Jun. 2021; 10(9): 711–731. DOI: 10.2217/CER-2020-0228
  8. Hernán MA, Wang W, and Leaf DE. Target Trial Emulation: A Framework for Causal Inference from Observational Data. JAMA. Dec. 2022; 328(24): 2446–2447 DOI: 10.1001/jama.2022.21383
  9. Mukhina SM, Baranova MI, Balykina YuYe. HARPER — shablon protokola po issledovaniyam real’noy klinicheskoy praktiki dlya otsenki effektivnosti lecheniya. Real’naya klinicheskaya praktika dannyye i dokazatel’stva. Dec. 2022; 2(4): 17–25. DOI: 10.37489/2782-3784-MYRWD-23 Russian.
  10. Wang SV, et al. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Pharmacoepidemiol Drug Saf. Jan. 2023; 32(1): 44–55. DOI: 10.1002/PDS.5507.
  11. Gatto NM, Vititoe SE, Rubinstein E, Reynolds RF and Campbell UB. A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses. Clin Pharmacol Ther. Jun. 2023; 113(6): 1235–1239. DOI: 10.1002/cpt.2883.
  12. Solodovnikov AG, Sorokina YeYu., Gol’dina TA. Dannyye rutinnoy praktiki (real-world data): ot planirovaniya k analizu. Meditsinskiye tekhnologii. Otsenka i vybor. 2020; 41(3): 9. DOI: 10.17116/ medtech2020410319 Russian.
  13. Gatto NM, et al. The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework. Clin Pharmacol Ther. Jan 2022; 111(1): 122–134 DOI: 10.1002/CPT.2466.
  14. Wang SV, et al. STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies. BMJ. Jan. 2021; 372 s. DOI: 10.1136/BMJ.M4856.